GR72886B - - Google Patents
Info
- Publication number
- GR72886B GR72886B GR58830A GR790158830A GR72886B GR 72886 B GR72886 B GR 72886B GR 58830 A GR58830 A GR 58830A GR 790158830 A GR790158830 A GR 790158830A GR 72886 B GR72886 B GR 72886B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782817988 DE2817988A1 (de) | 1978-04-25 | 1978-04-25 | Corticoid 17-alkylcarbonate und verfahren zu deren herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
GR72886B true GR72886B (el) | 1984-01-02 |
Family
ID=6037909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR58830A GR72886B (el) | 1978-04-25 | 1979-04-06 |
Country Status (19)
Country | Link |
---|---|
US (1) | US4377575A (el) |
EP (1) | EP0004975B1 (el) |
JP (1) | JPS54144357A (el) |
AR (1) | AR226157A1 (el) |
AT (1) | AT372094B (el) |
AU (1) | AU529172B2 (el) |
CA (1) | CA1130276A (el) |
DE (2) | DE2817988A1 (el) |
DK (1) | DK157880C (el) |
ES (2) | ES479709A1 (el) |
FI (1) | FI791307A (el) |
GR (1) | GR72886B (el) |
HU (1) | HU180788B (el) |
IE (1) | IE48328B1 (el) |
IL (1) | IL57114A (el) |
NO (1) | NO791365L (el) |
NZ (1) | NZ190256A (el) |
PT (1) | PT69544A (el) |
ZA (1) | ZA791941B (el) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE449106B (sv) * | 1980-07-10 | 1987-04-06 | Otsuka Pharma Co Ltd | Steroid med anti-inflammatorisk verkan samt komposition innehallande denna |
US4996335A (en) * | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
JPS5835199A (ja) * | 1981-08-26 | 1983-03-01 | Mitsubishi Chem Ind Ltd | モノヨ−ドステロイドおよびその製造法 |
JPS58103400A (ja) * | 1981-12-11 | 1983-06-20 | Ota Seiyaku Kk | 6α−メチルプレドニゾロン誘導体 |
JPS6056997A (ja) * | 1983-09-07 | 1985-04-02 | Mitsubishi Chem Ind Ltd | 新規な6−酸素化コルチコイド/7α−カ−ボネ−ト誘導体およびその製法 |
AU558725B2 (en) * | 1983-09-07 | 1987-02-05 | Mitsubishi Kasei Corporation | Corticoid derivatives |
DE4025342A1 (de) * | 1990-08-10 | 1992-02-13 | Hoechst Ag | In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
DE4328819A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE4333920A1 (de) | 1993-10-05 | 1995-04-13 | Hoechst Ag | Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
ES2292604T5 (es) * | 2000-08-05 | 2015-06-01 | Glaxo Group Limited | Éster S-fluorometílico del ácido 6 ,9 -difluoro-17 -[(2-furanilcarbonil)oxi]-11 -hidroxi-16 -metil-3-oxo-androsta-1,4-dien-17 -carbotioico como agente antiinflamatorio |
US6858593B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
CN1302007C (zh) * | 2001-04-30 | 2007-02-28 | 葛兰素集团有限公司 | 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.-硫代羧酸酯衍生物 |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US7208485B2 (en) * | 2003-01-13 | 2007-04-24 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
US20040138192A1 (en) * | 2003-01-13 | 2004-07-15 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
MX2010003698A (es) * | 2007-10-04 | 2010-04-21 | Astrazeneca Ab | Compuestos de [3,2-c]pirazol esteroides con actividad glucocorticoide. |
JP2011507836A (ja) * | 2007-12-20 | 2011-03-10 | アストラゼネカ・アクチエボラーグ | グルココルチコステロイド受容体アゴニストとして作用するステロイド誘導体 |
UY32523A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
UY32525A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
UY32521A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Combinación para emplear en el tratamiento de enfermedades respiratorias |
UY32520A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1253831A (en) * | 1968-01-19 | 1971-11-17 | Glaxo Lab Ltd | 9alpha,21-DIHALOPREGNANE COMPOUNDS |
GB1281689A (en) * | 1968-10-14 | 1972-07-12 | Glaxo Lab Ltd | Steroid 21-phosphates |
US3558675A (en) * | 1969-06-30 | 1971-01-26 | Merck & Co Inc | Steroid carbonates and process |
GB1440063A (en) * | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids |
US3832366A (en) * | 1973-07-30 | 1974-08-27 | Squibb & Sons Inc | Process for preparing 21-chloro-17-acyloxy-20-ketosteroids |
YU54476A (en) * | 1975-03-31 | 1982-05-31 | Taisho Pharmaceutical Co Ltd | Process for obtaining 17-ester 21-halo-pregnane |
US4021459A (en) * | 1975-08-14 | 1977-05-03 | Schering Corporation | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes |
DE2735110A1 (de) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung |
-
1978
- 1978-04-25 DE DE19782817988 patent/DE2817988A1/de not_active Ceased
-
1979
- 1979-04-06 GR GR58830A patent/GR72886B/el unknown
- 1979-04-19 ES ES479709A patent/ES479709A1/es not_active Expired
- 1979-04-20 EP EP79101200A patent/EP0004975B1/de not_active Expired
- 1979-04-20 DE DE7979101200T patent/DE2962122D1/de not_active Expired
- 1979-04-23 NZ NZ190256A patent/NZ190256A/xx unknown
- 1979-04-23 FI FI791307A patent/FI791307A/fi not_active Application Discontinuation
- 1979-04-23 IL IL57114A patent/IL57114A/xx unknown
- 1979-04-23 AR AR276277A patent/AR226157A1/es active
- 1979-04-24 CA CA326,264A patent/CA1130276A/en not_active Expired
- 1979-04-24 DK DK168579A patent/DK157880C/da not_active IP Right Cessation
- 1979-04-24 ZA ZA791941A patent/ZA791941B/xx unknown
- 1979-04-24 HU HU79HO2145A patent/HU180788B/hu not_active IP Right Cessation
- 1979-04-24 AT AT0307479A patent/AT372094B/de not_active IP Right Cessation
- 1979-04-24 NO NO791365A patent/NO791365L/no unknown
- 1979-04-24 JP JP5198879A patent/JPS54144357A/ja active Granted
- 1979-04-24 PT PT69544A patent/PT69544A/pt unknown
- 1979-04-24 AU AU46398/79A patent/AU529172B2/en not_active Ceased
- 1979-08-08 IE IE831/79A patent/IE48328B1/en unknown
-
1980
- 1980-01-31 ES ES488120A patent/ES488120A1/es not_active Expired
- 1980-12-15 US US06/216,258 patent/US4377575A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0004975A3 (en) | 1979-11-14 |
IE790831L (en) | 1979-10-25 |
ATA307479A (de) | 1983-01-15 |
ES479709A1 (es) | 1980-08-16 |
IL57114A0 (en) | 1979-07-25 |
DK157880C (da) | 1990-07-30 |
IL57114A (en) | 1983-11-30 |
US4377575A (en) | 1983-03-22 |
IE48328B1 (en) | 1984-12-12 |
EP0004975B1 (de) | 1982-02-17 |
HU180788B (en) | 1983-04-29 |
NO791365L (no) | 1979-10-26 |
DE2817988A1 (de) | 1979-11-08 |
AT372094B (de) | 1983-08-25 |
AR226157A1 (es) | 1982-06-15 |
JPS54144357A (en) | 1979-11-10 |
NZ190256A (en) | 1981-03-16 |
AU529172B2 (en) | 1983-05-26 |
CA1130276A (en) | 1982-08-24 |
DK168579A (da) | 1979-10-26 |
JPS6252759B2 (el) | 1987-11-06 |
ZA791941B (en) | 1980-04-30 |
DE2962122D1 (en) | 1982-03-25 |
EP0004975A2 (de) | 1979-10-31 |
PT69544A (de) | 1979-05-01 |
ES488120A1 (es) | 1980-09-16 |
FI791307A (fi) | 1979-10-26 |
DK157880B (da) | 1990-02-26 |